Page last updated: 2024-11-03

risperidone and Disruptive, Impulse Control, and Conduct Disorders

risperidone has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 7 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.

Research Excerpts

ExcerptRelevanceReference
"To examine whether subjective well-being and craving for cannabis were different in patients with schizophrenia or related disorders treated with either olanzapine or risperidone."9.13Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. ( de Haan, L; Linszen, D; van Beveren, NJ; van den Brink, W; van der Helm, M; van Nimwegen, LJ, 2008)
"To examine whether subjective well-being and craving for cannabis were different in patients with schizophrenia or related disorders treated with either olanzapine or risperidone."5.13Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. ( de Haan, L; Linszen, D; van Beveren, NJ; van den Brink, W; van der Helm, M; van Nimwegen, LJ, 2008)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Nimwegen, LJ1
de Haan, L1
van Beveren, NJ1
van der Helm, M1
van den Brink, W1
Linszen, D1
Klampfl, K1
Taurines, R1
Preuss, A1
Burger, R1
Rothenhöfer, S1
Wewetzer, Ch1
Pfuhlmann, B1
Fegert, J1
Gerlach, M1
Mehler-Wex, C1
Nakamae, T1
Yoo, JH1
Williams, DC1
Napolitano, DA1
Peyton, RT1
Baer, DM1
Schroeder, SR1
Stein, DJ1
Grant, JE1
Albanese, MJ1
Suh, JJ1
Hirose, S1

Reviews

1 review available for risperidone and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
[Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2011, Volume: 113, Issue:10

    Topics: Antipsychotic Agents; Autistic Disorder; Body Dysmorphic Disorders; Clomipramine; Comorbidity; Disru

2011

Trials

2 trials available for risperidone and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2008, Volume: 53, Issue:6

    Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Comorbidity; Disruptive, Impulse Control,

2008
Rate-decreasing effects of the atypical neuroleptic risperidone attenuated by conditions of reinforcement in a woman with mental retardation.
    Journal of applied behavior analysis, 2003,Summer, Volume: 36, Issue:2

    Topics: Adult; Antipsychotic Agents; Attention; Autistic Disorder; Behavior Therapy; Bipolar Disorder; Discr

2003

Other Studies

4 other studies available for risperidone and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Serum concentrations, therapeutic response and side effects in children and adolescents with impulsive-aggressive symptoms during risperidone therapy.
    Pharmacopsychiatry, 2010, Volume: 43, Issue:2

    Topics: Adolescent; Age Factors; Aggression; Antipsychotic Agents; Child; Child Behavior Disorders; Disrupti

2010
Betting on dopamine.
    CNS spectrums, 2005, Volume: 10, Issue:4

    Topics: Antipsychotic Agents; Brain; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impu

2005
Risperidone in cocaine-dependent patients with comorbid psychiatric disorders.
    Journal of psychiatric practice, 2006, Volume: 12, Issue:5

    Topics: Adolescent; Adult; Antipsychotic Agents; Cocaine-Related Disorders; Comorbidity; Counseling; Diagnos

2006
Effective treatment of aggression and impulsivity in antisocial personality disorder with risperidone.
    Psychiatry and clinical neurosciences, 2001, Volume: 55, Issue:2

    Topics: Adult; Aggression; Antipsychotic Agents; Antisocial Personality Disorder; Disruptive, Impulse Contro

2001